celiprolol has been researched along with fibrinogen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feely, J; Holden, RD; Johnston, GD; Radley, DR; Vyssoulis, G | 1 |
| Kendall, MJ; Rajman, I | 1 |
| Arapogianni, AN; Aznaouridis, KA; Cokkinos, DV; Karpanou, EA; Marinakis, AG; Stefanadis, CI; Vyssoulis, GP | 1 |
1 review(s) available for celiprolol and fibrinogen
| Article | Year |
|---|---|
A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Carbohydrate Metabolism; Cardiovascular Diseases; Celiprolol; Drug Tolerance; Fibrinogen; Heart; Humans; Kidney; Respiratory System; Risk Factors | 1994 |
1 trial(s) available for celiprolol and fibrinogen
| Article | Year |
|---|---|
Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
Topics: Adult; Aged; Blood Pressure; Celiprolol; Double-Blind Method; Female; Fibrinogen; Heart Rate; Humans; Hyperlipidemias; Hypertension; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Metoprolol; Middle Aged; Peak Expiratory Flow Rate; Treatment Outcome | 1995 |
1 other study(ies) available for celiprolol and fibrinogen
| Article | Year |
|---|---|
The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smoking.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzopyrans; Biomarkers; Blood Pressure; Carbazoles; Carvedilol; Celiprolol; Endothelium, Vascular; Ethanolamines; Female; Fibrinogen; Homocystine; Humans; Hypertension; Male; Middle Aged; Nebivolol; Plasminogen Activator Inhibitor 1; Propanolamines; Smoking; Treatment Outcome; Vasodilation | 2004 |